A detailed history of First National Trust CO transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, First National Trust CO holds 4,178 shares of EW stock, worth $272,238. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,178
Previous 4,106 1.75%
Holding current value
$272,238
Previous $392,000 1.79%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$84.3 - $94.31 $6,069 - $6,790
72 Added 1.75%
4,178 $385,000
Q1 2024

Apr 26, 2024

BUY
$72.54 - $95.56 $44,321 - $58,387
611 Added 17.48%
4,106 $392,000
Q4 2023

Feb 06, 2024

BUY
$61.71 - $77.76 $3,270 - $4,121
53 Added 1.54%
3,495 $266,000
Q3 2023

Nov 06, 2023

SELL
$69.28 - $93.38 $7,967 - $10,738
-115 Reduced 3.23%
3,442 $238,000
Q2 2023

Aug 01, 2023

SELL
$81.41 - $94.33 $24,178 - $28,016
-297 Reduced 7.71%
3,557 $335,000
Q1 2023

Apr 26, 2023

BUY
$74.26 - $84.51 $10,470 - $11,915
141 Added 3.8%
3,854 $318,000
Q4 2022

Feb 02, 2023

BUY
$68.3 - $87.44 $16,118 - $20,635
236 Added 6.79%
3,713 $277,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $7,742 - $10,085
-94 Reduced 2.63%
3,477 $287,000
Q2 2022

Aug 03, 2022

SELL
$86.5 - $128.27 $32,264 - $47,844
-373 Reduced 9.46%
3,571 $340,000
Q1 2022

May 03, 2022

SELL
$101.96 - $128.34 $13,764 - $17,325
-135 Reduced 3.31%
3,944 $464,000
Q4 2021

Feb 03, 2022

BUY
$106.37 - $130.68 $2,340 - $2,874
22 Added 0.54%
4,079 $528,000
Q3 2021

Nov 05, 2021

SELL
$102.91 - $122.75 $41,472 - $49,468
-403 Reduced 9.04%
4,057 $459,000
Q2 2021

Aug 06, 2021

SELL
$83.84 - $104.76 $58,017 - $72,493
-692 Reduced 13.43%
4,460 $462,000
Q1 2021

May 06, 2021

BUY
$78.68 - $90.67 $5,586 - $6,437
71 Added 1.4%
5,152 $431,000
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $25,163 - $32,021
-351 Reduced 6.46%
5,081 $464,000
Q3 2020

Nov 04, 2020

SELL
$67.19 - $87.44 $20,358 - $26,494
-303 Reduced 5.28%
5,432 $434,000
Q2 2020

Aug 06, 2020

BUY
$57.54 - $76.95 $202,253 - $270,479
3,515 Added 158.33%
5,735 $396,000
Q1 2020

Apr 29, 2020

SELL
$52.41 - $81.0 $60,952 - $94,203
-1,163 Reduced 34.38%
2,220 $419,000
Q4 2019

Feb 04, 2020

SELL
$71.7 - $82.09 $47,823 - $54,754
-667 Reduced 16.47%
3,383 $789,000
Q3 2019

Nov 01, 2019

SELL
$61.55 - $75.43 $63,211 - $77,466
-1,027 Reduced 20.23%
4,050 $891,000
Q2 2019

Jul 22, 2019

SELL
$55.74 - $64.41 $699,314 - $808,087
-12,546 Reduced 71.19%
5,077 $938,000
Q1 2019

Apr 25, 2019

SELL
$47.89 - $64.05 $737,506 - $986,370
-15,400 Reduced 46.63%
17,623 $3.37 Million
Q4 2018

Jan 28, 2019

BUY
$46.41 - $56.94 $467,673 - $573,784
10,077 Added 43.92%
33,023 $5.06 Million
Q3 2018

Oct 31, 2018

BUY
$45.7 - $58.03 $104,333 - $132,482
2,283 Added 11.05%
22,946 $0
Q2 2018

Jul 30, 2018

BUY
$42.45 - $51.3 $49,878 - $60,277
1,175 Added 6.03%
20,663 $3.01 Million
Q1 2018

Apr 30, 2018

BUY
$37.19 - $47.45 $118,636 - $151,365
3,190 Added 19.57%
19,488 $2.72 Million
Q4 2017

Jan 17, 2018

BUY
$33.79 - $39.39 $241,057 - $281,008
7,134 Added 77.85%
16,298 $1.84 Million
Q3 2017

Nov 06, 2017

BUY
$36.29 - $38.83 $39,302 - $42,052
1,083 Added 13.4%
9,164 $1 Million
Q2 2017

Aug 07, 2017

BUY
N/A
8,081
8,081 $955,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.3B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track First National Trust CO Portfolio

Follow First National Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First National Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on First National Trust CO with notifications on news.